Merck

ZINPLAVA

Manufacturer:

Merck

Zinplava HCPCS:

J0565

HCPCS Code Descriptor:

Injection, bezlotoxumab, 10 mg

Category:

J Code

Zinplava NDCs:

00006-3025-00

Primary Type:

Unclassified

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Zinplava CPT Codes:

Potential CPT administration codes for Zinplava can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Zinplava:

ZINPLAVA is an Unclassified drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J0565 is aligned to the drug ZINPLAVA.

ACCESS PRICING AND MORE BY REGISTERING

J0565 Added Date:

January 1, 2018

J0565 Effective Date:

January 1, 2018

J0565 Termination Date:

HCPCS Active

Zinplava billing and coding information can be found through Merck at the link below:
Zinplava patient assistance information can be found through the Merck Access Program at the URL: http://www.merckaccessprogram.com/hcp/
ZINPLAVA prescribing information can be found at the link below:
Information regarding ZINPLAVA’s side effects can be found at MedlinePlus